Home / Companies / News / Ranbaxy gets USFDA nod for Loperamide

Ranbaxy gets USFDA nod for Loperamide

Last Updated : Jan 28 2013 | 7:04 PM IST

Our Web Bureau / Mumbai September 11, 2006

Ranbaxy Laboratories has received approval from the US Food and Drug Administration (USFDA) to manufacture and market Loperamide Hydrochloride and Simethicone Tablets, 2 mg/125 mg.

According to a release issued by Ranbaxy to the BSE today, the Office of Generic Drugs, USFDA, has determined the company's Loperamide Hydrochloride and Simethicone Tablets to be bioequivalent to the reference listed drug (RLD) Imodium